COST EFFECTIVENESS OF ORAL PERICALCITOL IN PATIENTS WITH STAGE III-IV CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYREOSIS

QR Code

COST EFFECTIVENESS OF ORAL PERICALCITOL IN PATIENTS WITH STAGE III-IV CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYREOSIS

results of clinical trials demonstrate that selective vitamin D receptor agonist paricalcitoldecreases proteinuria in patients with chronic kidney disease (CKD) and hyperparathyreosis.

Saved in:

Bibliographic Details
Main Author:	A. V. Rudakova
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2015-03-01
Series:	Фармакоэкономика
Subjects:	secondary hyperparathyreosis nephropathy dialysis vitamin d receptor agonist cost effectiveness analysis markov model
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/28
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Screeing of Patients with Essential Hypertension as a Prevention Method Hypertensive Nephropathy
by: M. M. Batyushin, et al.
Published: (2012-03-01)

The Role of Vitamin D and Its Receptor Signaling in Diabetic Nephropathy and the Current Status of Research: A Literature Review
by: Qiaoya He, et al.
Published: (2025-04-01)

ANALGESIC POTENTIAL OF PURINE RECEPTOR AGONISTS AND B VITAMINS IN THE TREATMENT OF DIABETIC POLYNEUROPATHY
by: O. A. Demidova, et al.
Published: (2018-03-01)

Diagnostic potential of soluble TNF alpha receptor 1 in diabetic and hypertensive patients with renal impairment and UTI.
by: Fatin Ayoob Hameed, et al.
Published: (2020-02-01)

FACTORS ASSOCIATED WITH THE DEVELOPMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH TYPE 1 DIABETES MELLITUS WITH DIABETIC NEPHROPATHY
by: Ye. A. Khantakova
Published: (2014-04-01)

Treatment of patients with refractory immune thrombocytopenia: literature review and case report
by: V. V. Ptushkin, et al.
Published: (2014-07-01)

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?
by: D. V. Nebieridze, et al.
Published: (2015-12-01)

Long-term analysis of сanagliflozin budget impact in adult patients with type 2 diabetes mellitus and diabetic nephropathy in the Russian Federation
by: N. A. Avxentyev, et al.
Published: (2022-10-01)

Association of TLR4 expression and genomic instability with renal function markers in diabetic nephropathy
by: Ayat Rasheed Hameed, et al.
Published: (2025-06-01)

Treatment of irritable bowel syndrome: the past, present and future
by: V. T. Ivashkin, et al.
Published: (2015-03-01)

Exp erimental research of wearable artificial kidney
by: N. A. Bazaev, et al.
Published: (2017-09-01)

Results of long-term treatment with thrombopoietin receptor agonists of resistant primary immune thrombocytopenia
by: O. Yu. Vinogradova, et al.
Published: (2024-12-01)

Place of imidazoline receptor agonists in the treatment of arterial hypertension
by: D. V. Nebieridze, et al.
Published: (2023-12-01)

Role of zinc and vitamin D in modulating diabetic nephropathy in experimental models
by: Mahmoud Fadl Bakr, et al.
Published: (2025-07-01)

Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies
by: Héctor Iván Saldívar-Cerón, et al.
Published: (2025-06-01)

Kidney transplantation with preformed diabetic nephropathy kidney: review of pathological changes and clinical outcomes
by: Shujing Li, et al.
Published: (2025-07-01)

Efficacy and Safety of Low‐Dose Spironolactone in Management of Diabetic Kidney Disease in a Real‐World Setting
by: Manochehr Amini, et al.
Published: (2025-07-01)

Development of Novel Tavapadon Analogs as Dual-targeted Partial Agonists Based on the Dopamine D<sub>1</sub>/D<sub>5</sub> Receptors
by: Fan Shi, et al.

Augmentation Therapy With Serotonin 5‐HT1A Receptor Partial Agonists on Cognitive Function in Depressive Disorders: A Systematic Review of Randomized Controlled Studies
by: Risa Yamada, et al.
Published: (2025-06-01)

Complications of thrombopoietin receptor agonists therapy in patients with immune thrombocytopenia
by: S. G. Zakharov, et al.
Published: (2024-04-01)

Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
by: D. J. Kuter, et al.
Published: (2015-01-01)

The Potential Role of Glucagon-Like Peptide-1 Receptor Agonists in Polycystic Ovary Syndrome: A Narrative Review
by: Kamil Turlej, et al.
Published: (2025-07-01)

IgA Nephropathy in a HIV Positive Patient: A Rare Case Scenario
by: Anuja Makan, et al.
Published: (2025-08-01)

The role of cannabinoid agonists and antagonists on folliculogenesis and evolutionary events in the mouse ovary
by: Vida Mirzaie, et al.
Published: (2025-09-01)

A comparative qualitative assessment of the severity of diabetic retinopathy in patients with stages III, IV and V, requiring hemodialysis, of chronic renal insufficiency
by: A. S. Golovin, et al.
Published: (2022-12-01)

Factors related to depression in patients with dialysis chronic kidney disease: a cross-sectional study
by: Septa Meriana Lumbantoruan, et al.
Published: (2025-06-01)

Impact of Serum Magnesium Levels on Mineral-Bone Metabolism in Non-Dialysis-Dependent Chronic Kidney Disease
by: Cao YP, et al.
Published: (2025-06-01)

Imidazoline receptor agonists and left ventricular hypertrophy
by: L. L. Kirichenko, et al.
Published: (2005-04-01)

SUGGESTED CONSERVATIVE APPROACH TO PREVENTION OF LATE RECURRENT ATRIAL FIBRILLATION AFTER CATHETER ABLATION (PILOT STUDY)
by: B. A. Tatarsky
Published: (2018-03-01)

Pulmonary artery pressure trajectories in heart failure patients treated with GLP‐1 receptor agonists
by: Haoran Jiang, et al.
Published: (2025-08-01)

GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
by: Giulia Migliorisi, et al.
Published: (2025-07-01)

Improving the Quality of Two Lives by Treating Obesity
by: Norbert Nagy, et al.
Published: (2025-06-01)

Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society
by: Dariush Mozaffarian, et al.
Published: (2025-09-01)

Medical Comorbidities as the Independent Risk Factors of Severe Adenovirus Respiratory Tract Infection in Adults
by: Wang Chun Kwok, et al.
Published: (2025-07-01)

Acute Kidney Injury in Patients With Acute Chemical Poisoning: the Experience of the Toxicological Center in Ryazan
by: N. V. Shatrova, et al.
Published: (2021-01-01)

Association between A1166C Polymorphism of the Angiotensin II Type-1 Receptor Gene and Type-2 Diabetic Nephropathy in an Indonesian Malay Population
by: Zulkhair Ali, et al.
Published: (2019-01-01)

Association between A1166C Polymorphism of the Angiotensin II Type-1 Receptor Gene and Type-2 Diabetic Nephropathy in an Indonesian Malay Population
by: Zulkhair Ali, et al.
Published: (2019-01-01)

Adenosine A<sub>2B</sub> Receptor Antagonism Interferes with TGF-β Cellular Signaling Through SMAD2/-3 and p65-Nf-κB in Podocytes and Protects from Phenotypical Transformation in Experimental Diabetic Glomerulopathy
by: Ignacio Arias, et al.
Published: (2025-06-01)

A rare case of acute destructive pancreatitis in a patient with chronic kidney disease on peritoneal dialysis: diagnostic and treatment challenges
by: V. A. Stepanov, et al.
Published: (2024-01-01)

Molecular mechanisms of novel selective glucocorticoid receptor agonist action in breast cancer cells
by: E. M. Zhidkova, et al.
Published: (2024-10-01)